Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing

BACKGROUND: The exploitation of anti-tumour immunity, harnessed through immunomodulatory therapies, has fundamentally changed the treatment of primary liver cancer (PLC). However, this has posed significant challenges in preclinical research. Novel immunologically relevant models for PLC are urgentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagatia, Ravi, Doornebal, Ewald J., Rastovic, Una, Harris, Nicola, Feyide, Moyosoreoluwa, Lyons, Anabel Martinez, Miquel, Rosa, Zen, Yoh, Zamalloa, Ane, Malik, Farooq, Prachalias, Andreas, Menon, Krishna, Boulter, Luke, Eaton, Simon, Heaton, Nigel, Phillips, Sandra, Chokshi, Shilpa, Palma, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667128/
https://www.ncbi.nlm.nih.gov/pubmed/37806285
http://dx.doi.org/10.1016/j.ebiom.2023.104826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667128/
https://www.ncbi.nlm.nih.gov/pubmed/37806285
http://dx.doi.org/10.1016/j.ebiom.2023.104826

Ejemplares similares